Long-term outcome of kidney function in patients with ANCA-associated vasculitis

被引:7
|
作者
Sachez-Alamo, Beatriz [1 ,2 ]
Moi, Laura [3 ]
Bajema, Ingeborg [4 ]
Berden, Annelies [5 ]
Flossmann, Oliver [6 ]
Hruskova, Zdenka [7 ]
Jayne, David [8 ]
Wester-Trejo, Maria [9 ]
Wallquist, Carin [10 ]
Westman, Kerstin [11 ]
机构
[1] Lund Univ, Dept Clin Sci Lund, Div Nephrol, Lund, Sweden
[2] Hosp Univ Sureste, Dept Nephrol, Madrid, Spain
[3] Univ Hosp Lausanne, Lausanne Univ, Dept Med, Div Immunol & Allergy, Lausanne, Switzerland
[4] Dept Pathol, Groningen, Netherlands
[5] Maasstad Hosp, Dept Rheumatol & Clin Immunol, Rotterdam, Netherlands
[6] Royal Berkshire Hosp, Dept Nephrol, Reading, England
[7] Charles Univ Prague, Gen Hosp Prague, Fac Med 1, Dept Nephrol, Prague, Czech Republic
[8] Univ Cambridge, Dept Med, Cambridge, England
[9] Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands
[10] Skane Univ, Hosp Malmo, Dept Nephrol, Malmo, Sweden
[11] Lund Univ, Dept Clin Sci Lund, Div Nephrol, Lund, Sweden
关键词
ANCA-associated vasculitis; end-stage kidney disease; kidney histology scores; prognosis; transplantation; ANTIBODY-ASSOCIATED VASCULITIS; HISTOPATHOLOGICAL CLASSIFICATION; SPANISH REGISTRY; RENAL VASCULITIS; GLOMERULONEPHRITIS; BIOPSY; SURVIVAL; PROPOSAL; WEGENER; TRIALS;
D O I
10.1093/ndt/gfae018
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Kidney involvement is common in anti-neutrophil cytoplasm antibody-associated vasculitis (AAV) and the prognosis is determined by the severity of kidney damage. This study focused on long-term kidney outcomes, defining possible risk factors and comparing the performance of three different histological classifications to predict outcomes for patients with AAV. Methods. The dataset included 848 patients with newly diagnosed AAV who participated in seven randomized controlled trials (RCTs) (1995-2012). Follow-up information was obtained from questionnaires sent to the principal investigators of the original RCTs. Results. The cumulative incidence of end-stage kidney disease (ESKD) at 5 and 10 years was 17% and 22%, respectively. Patients who developed ESKD had reduced patient survival compared with those with preserved kidney function (hazard ratio 2.8, P < .001). Comparing patients with AAV and kidney involvement with a matched general population, patients with AAV had poor survival outcomes, even in early stages of chronic kidney disease. The main cause of death was infection followed by cardiovascular disease in patients developing ESKD and malignancy in those who did not. Some 34% of patients with initial need for dialysis recovered kidney function after treatment. Thirty-five out of 175 in need of kidney replacement therapy (KRT) during follow-up received a kidney transplant with good outcome; there was 86% patient survival at 10 years. In the subcohort of 214 patients with available kidney biopsies, three scoring systems were tested: the Berden classification, the Renal Risk Score and the Mayo Clinic Score. The scores highlighted the importance of normal glomeruli and severe glomerulosclerosis on kidney survival (P < .001 and P = .001, respectively). The Renal Risk Score demonstrated a moderate prediction of kidney survival (area under the curve 0.79; standard error 0.03, 95% confidence interval 0.71-0.83). Conclusions Early diagnosis of AAV is extremely important. Even milder forms of kidney involvement have an impact on the prognosis. Patients in need of KRT had the lowest survival rates, but kidney transplantation has shown favorable outcomes for eligible AAV patients. The three histologic scoring systems were all identified as independent prognostic factors for kidney outcome.
引用
收藏
页码:1483 / 1493
页数:11
相关论文
共 50 条
  • [21] Complications of long-term therapy for ANCA-associated systemic vasculitis
    Nadezhda Wall
    Lorraine Harper
    Nature Reviews Nephrology, 2012, 8 : 523 - 532
  • [22] Complications of long-term therapy for ANCA-associated systemic vasculitis
    Wall, Nadezhda
    Harper, Lorraine
    NATURE REVIEWS NEPHROLOGY, 2012, 8 (09) : 523 - 532
  • [23] Good long-term results for rituximab in ANCA-associated vasculitis
    Nature Clinical Practice Rheumatology, 2007, 3 (2): : 64 - 65
  • [24] Long-term outcome of severe alveolar hemorrhage in ANCA-associated vasculitis: A retrospective cohort study
    Hruskova, Z.
    Casian, A.
    Konopasek, P.
    Svobodova, B.
    Frausova, D.
    Lanska, V.
    Tesar, V.
    Jayne, D.
    PRESSE MEDICALE, 2013, 42 (04): : 752 - 752
  • [25] Long-term outcome of severe alveolar haemorrhage in ANCA-associated vasculitis: a retrospective cohort study
    Hruskova, Z.
    Casian, A. L.
    Konopasek, P.
    Svobodova, B.
    Frausova, D.
    Lanska, V.
    Tesar, V.
    Jayne, D. R. W.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2013, 42 (03) : 211 - 214
  • [26] Kidney function as a predictor of relapse in ANCA-associated vasculitis
    Lwin, Khin Zar Li
    Tan, Shi Yun
    Lim, Cynthia C.
    KIDNEY INTERNATIONAL, 2025, 107 (02) : 359 - 359
  • [27] Long-term safety and efficacy of rituximab in 7 Japanese patients with ANCA-associated vasculitis
    Nagafuchi, Hiroko
    Atsumi, Tatsuya
    Hatta, Kazuhiro
    Muso, Eri
    Takeno, Mitsuhiro
    Yamada, Hidehiro
    Ozaki, Shoichi
    MODERN RHEUMATOLOGY, 2015, 25 (04) : 603 - 608
  • [28] PULMONARY FUNCTION IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS
    Dieterich, Johannes
    Hellmich, Bernhard
    Mahrhold, Juliane
    Feng, You-Shan
    El Rai, Abdallah
    Nessyt, Felix
    Specks, Ulrich
    Hetzel, Juergen
    Loeffler, Christian
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2024, 41 (02)
  • [29] AN AUDIT OF THE PREVENTION OF LONG TERM COMPLICATIONS IN PATIENTS WITH AN ANCA-ASSOCIATED VASCULITIS
    Amin, M. Naushad
    Brown, N.
    Venning, M.
    Haque, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1094 - 1094
  • [30] Risks of treatments and long-term outcomes of systemic ANCA-associated vasculitis
    Flossmann, Oliver
    PRESSE MEDICALE, 2015, 44 (06): : E251 - E257